Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Negri

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Critical Reviews in Oncology/Hematology|February 25, 2016
Second-line angiogenesis inhibition in metastatic colorectal cancer patients: Straightforward or overcrowded?Riccardo Giampieri, Marta Caporale, Filippo Pietrantonio, et al.
British Journal of Cancer|December 19, 2007
Biological predictive factors in rectal cancer treated with preoperative radiotherapy or radiochemotherapyF V Negri, N Campanini, R Camisa, et al.
The Pharmacogenomics Journal|January 9, 2013
Role of immunoglobulin G fragment C receptor polymorphism-mediated antibody-dependant cellular cytotoxicity in colorectal cancer treated with cetuximab therapyF V Negri, A Musolino, N Naldi, et al.
Oncotarget|September 11, 2016
Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenibAndrea Casadei Gardini, Emanuela Scarpi, Luca Faloppi, et al.
Critical Reviews in Oncology/Hematology|June 13, 2017
Second-line chemotherapy for advanced pancreatic cancer: Which is the best option?Giuseppe Aprile, Francesca V Negri, Francesco Giuliani, et al.
Frontiers in Oncology|November 12, 2019
A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 1 (Head and Neck Surgery)Pavel Dulguerov, Martina A Broglie, Guido Henke, et al.
Frontiers in Oncology|November 12, 2019
A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 2 (Radiation Oncology)Olgun Elicin, Paul Martin Putora, Marco Siano, et al.
Frontiers in Oncology|November 12, 2019
A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 3 (Medical Oncology)Marco Siano, Pavel Dulguerov, Martina A Broglie, et al.
Frontiers in Oncology|November 12, 2019
A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 4 (Biomarkers)Martina A Broglie, Pavel Dulguerov, Guido Henke, et al.
British Journal of Cancer|April 14, 2011
Comparison of HER2 status in primary and paired metastatic sites of gastric carcinomaC Bozzetti, F V Negri, C A Lagrasta, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Critical Reviews in Oncology/Hematology|February 25, 2016
Second-line angiogenesis inhibition in metastatic colorectal cancer patients: Straightforward or overcrowded?Riccardo Giampieri, Marta Caporale, Filippo Pietrantonio, et al.
British Journal of Cancer|December 19, 2007
Biological predictive factors in rectal cancer treated with preoperative radiotherapy or radiochemotherapyF V Negri, N Campanini, R Camisa, et al.
The Pharmacogenomics Journal|January 9, 2013
Role of immunoglobulin G fragment C receptor polymorphism-mediated antibody-dependant cellular cytotoxicity in colorectal cancer treated with cetuximab therapyF V Negri, A Musolino, N Naldi, et al.
Oncotarget|September 11, 2016
Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenibAndrea Casadei Gardini, Emanuela Scarpi, Luca Faloppi, et al.
Critical Reviews in Oncology/Hematology|June 13, 2017
Second-line chemotherapy for advanced pancreatic cancer: Which is the best option?Giuseppe Aprile, Francesca V Negri, Francesco Giuliani, et al.
Frontiers in Oncology|November 12, 2019
A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 1 (Head and Neck Surgery)Pavel Dulguerov, Martina A Broglie, Guido Henke, et al.
Frontiers in Oncology|November 12, 2019
A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 2 (Radiation Oncology)Olgun Elicin, Paul Martin Putora, Marco Siano, et al.
Frontiers in Oncology|November 12, 2019
A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 3 (Medical Oncology)Marco Siano, Pavel Dulguerov, Martina A Broglie, et al.
Frontiers in Oncology|November 12, 2019
A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 4 (Biomarkers)Martina A Broglie, Pavel Dulguerov, Guido Henke, et al.
British Journal of Cancer|April 14, 2011
Comparison of HER2 status in primary and paired metastatic sites of gastric carcinomaC Bozzetti, F V Negri, C A Lagrasta, et al.
Pageof 5